Articles

2022

The controversy around falsified Alzheimer’s research

October 24, 2022

Read about NervGen and its research in Alzheimer’s in this article in Health Europa

With Some Help, Small Canadian Biotech Could Challenge Roche's Hold in Stroke Treatment

July 29, 2022

Read about NervGen and our preclinical results in stroke in this article in BioSpace

Stroke drug improves memory and repairs injured brain tissue in mice

July 28, 2022

New Scientist’s Carissa Wong writes about NervGen’s potential in stroke following Cell Reports publication

Biotechnology’s Role in Improving Stroke Outcomes

July 18, 2022

Article in Contract Pharma by NervGen President & CEO, Paul Brennan, on the role of Biotech in improving Stroke outcomes.

2021

Defining a Successful Biotechnology Entrepreneur

April 16, 2021

BioProcess International

BioProcess International features a byline from Paul Brennan.

NervGen (TSX-V: NGEN, OTCQX: NGENF) is a clinical stage biotech company creating innovative treatments that enable the nervous system to repair itself following damage. The company’s initial focus is on spinal cord injury, Alzheimer’s and multiple sclerosis.

Contact

2955 Virtual Way
Suite 480
Vancouver, BC V5M 4X6

Phone: (778) 731-1711
Email: info@nervgen.com

Subscribe for Updates

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others